Funguria in Hospitalized Patients
NCT00138502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 926
Last updated 2019-02-04
Summary
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
Conditions
- Candidiasis
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-17
- Primary Completion
- 2008-12-08
- Completion
- 2008-12-08
Countries
- United States
Study Locations
More Related Trials
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002339 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002304 ·Status: COMPLETED ·Phase: NA
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
Early- and Late-onset Candidemia
NCT01406093 ·Status: COMPLETED
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
NCT01077336 ·Status: COMPLETED
-
Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital
NCT00903526 ·Status: UNKNOWN
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
NCT00002038 ·Status: COMPLETED ·Phase: NA
-
Fungal Infection Susceptibility
NCT00001352 ·Status: RECRUITING
-
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 ·Status: COMPLETED ·Phase: PHASE2
-
Efflux Pump Mediated Azole Resistance in Candida Albicans
NCT03659162 ·Status: UNKNOWN
-
Echinocandins Versus Azoles for Candidemia Treatment
NCT03799172 ·Status: COMPLETED
-
Risk Factor and Outcome of Candidemia
NCT01249313 ·Status: UNKNOWN
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.
NCT03674359 ·Status: UNKNOWN
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
NCT00721487 ·Status: COMPLETED
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3